โก Quick Summary
This study identified three core biomarkers for endometriosis (EM) using a combination of genome-wide association studies and machine learning. The findings highlight the potential for noninvasive diagnosis and personalized treatment options for EM patients.
๐ Key Details
- ๐ Dataset: Genome-wide association study dataset from FinnGen
- ๐งฌ Techniques used: Multi-marker Analysis of GenoMic Annotation (MAGMA), single-cell RNA sequencing, consensus clustering
- โ๏ธ Machine Learning: Employed to select key biomarkers
- ๐ Identified biomarkers: Adenosine kinase, enoyl-CoA hydratase/3-hydroxyacyl CoA dehydrogenase, CCR4-NOT transcription complex subunit 7
๐ Key Takeaways
- ๐ฌ Endometriosis significantly affects quality of life and is often diagnosed through invasive surgery.
- ๐ก Noninvasive biomarkers are urgently needed for early diagnosis and personalized treatment.
- ๐ MAGMA analysis identified 2832 genes significantly associated with EM.
- ๐งฌ 3055 differentially expressed genes (DEGs) were detected, leading to 437 MAGMA-related DEGs.
- ๐ Summary-data-based Mendelian randomization identified 10 candidate genes.
- ๐ค Machine learning validated three core biomarkers with protective roles in EM.
- ๐ Single-cell RNA sequencing revealed distinct expression patterns of these biomarkers.
- ๐๏ธ Consensus clustering classified EM samples into two subgroups with differing immune cell compositions.
๐ Background
Endometriosis is a chronic condition that affects millions of women worldwide, often leading to debilitating pain and fertility issues. Traditional diagnostic methods rely heavily on surgical intervention, which can be risky and may overlook early-stage lesions. The need for noninvasive biomarkers is critical for improving early diagnosis and tailoring treatment strategies to individual patients.
๐๏ธ Study
The study utilized data from the FinnGen genome-wide association study to explore genetic associations with endometriosis. Researchers employed Multi-marker Analysis of GenoMic Annotation (MAGMA) to identify genes linked to EM, followed by an analysis of differentially expressed genes (DEGs). The study also incorporated machine learning techniques to refine the selection of potential biomarkers.
๐ Results
The analysis revealed a total of 2832 genes significantly associated with endometriosis, with 3055 DEGs identified. Through intersection analysis, 437 MAGMA-related DEGs were determined. The study successfully pinpointed three core biomarkers: adenosine kinase, enoyl-CoA hydratase/3-hydroxyacyl CoA dehydrogenase, and CCR4-NOT transcription complex subunit 7, which were validated as having protective roles in EM.
๐ Impact and Implications
The identification of these biomarkers could significantly enhance the diagnostic landscape for endometriosis, paving the way for noninvasive testing methods that could improve patient outcomes. By understanding the molecular characteristics of EM and its subgroups, healthcare providers can develop more personalized treatment plans, ultimately improving the quality of life for those affected by this challenging condition.
๐ฎ Conclusion
This study underscores the potential of combining genetic analysis with machine learning to identify critical biomarkers for endometriosis. The findings not only contribute to the understanding of EM but also open avenues for innovative diagnostic approaches that could transform patient care. Continued research in this area is essential to further validate these biomarkers and explore their clinical applications.
๐ฌ Your comments
What are your thoughts on the potential of these biomarkers for improving endometriosis diagnosis and treatment? We invite you to share your insights in the comments below or connect with us on social media:
Identification of biomarkers for endometriosis based on summary-data-based Mendelian randomization and machine learning.
Abstract
Endometriosis (EM) significantly impacts the quality of life, and its diagnosis currently relies on surgery, which carries risks and may miss early lesions. Noninvasive biomarkers are urgently needed for early diagnosis and personalized treatment. This study utilized the genome-wide association study dataset from FinnGen and performed Multi-marker Analysis of GenoMic Annotation (MAGMA) to identify genes significantly associated with EM. Differentially expressed genes (DEGs) were then analyzed, and an intersection selection was conducted to obtain the MAGMA-related DEGs. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed to explore the biological functions of these genes. Summary-data-based Mendelian randomization was used to identify potential risk and protective genes. Subsequently, a machine learning model was used to further select key biomarkers. Single-cell RNA sequencing and consensus clustering were applied to analyze the expression of biomarkers and classify the EM samples into subgroups. Immune infiltration analysis was conducted to evaluate the molecular characteristics of these subgroups. MAGMA analysis identified 2832 genes significantly associated with EM, while 3055 DEGs were detected. Intersection analysis resulted in 437 MAGMA-related DEGs. Summary-data-based Mendelian randomization analysis identified 10 candidate genes, and after further selection using a machine learning model, three core biomarkers were validated: adenosine kinase, enoyl-CoA hydratase/3-hydroxyacyl CoA dehydrogenase, and CCR4-NOT transcription complex subunit 7. Single-cell RNA sequencing revealed the expression patterns of these biomarkers. Consensus clustering analysis classified 77 EM samples into two subgroups, with immune infiltration analysis showing significant differences in immune cell composition among the subgroups. This study successfully identified three core biomarkers for EM: adenosine kinase, enoyl-CoA hydratase/3-hydroxyacyl CoA dehydrogenase, and CCR4-NOT transcription complex subunit 7, which exhibit protective roles in EM.
Author: [‘Xie Z’, ‘Feng Y’, ‘He Y’, ‘Lin Y’, ‘Wang X’]
Journal: Medicine (Baltimore)
Citation: Xie Z, et al. Identification of biomarkers for endometriosis based on summary-data-based Mendelian randomization and machine learning. Identification of biomarkers for endometriosis based on summary-data-based Mendelian randomization and machine learning. 2025; 104:e41804. doi: 10.1097/MD.0000000000041804